Long-term studies have shown that CTL is determinant of the outcome; for example, in Japanese cohorts, HLA-A*02 and HLA-C*08 play a protective role against the development of HAM/TSP, whereas HLA-B*54 is associated with a higher risk. This evidence concerns the gene HLA-A and tropical spastic paraparesis.